Company Overview and News

The Green Organic Dutchman Receives Organic Certification From Internationally Recognized Ecocert Canada

2018-05-18 globenewswire
TORONTO, May 18, 2018 (GLOBE NEWSWIRE) -- The Green Organic Dutchman Holdings Ltd. (the “Company” or “TGOD”) (TSX:TGOD) is pleased to announce that on May 9, 2018 its facility based in Ancaster, Ontario received organic certification from Ecocert Canada, an internationally recognized world-leading organization in organic certification.

CANADA STOCKS-TSX flat as health stocks offset losses in financials

2018-05-18 reuters
May 18 (Reuters) - Canada’s main stock index was trading flat on Friday as a rise in healthcare stocks offset a drop in financial shares after inflation data lifted expectations the central bank will hold interest rates steady later this month.

PI Financial Cuts Aurora Cannabis’s Price Target

2018-05-17 marketrealist
On May 14, Aurora Cannabis (ACB) (ACBFF) announced that it agreed to acquire all of MedReleaf’s (MEDFF) outstanding common shares for about 3.2 billion Canadian dollars in one of the biggest deals in the cannabis sector (MJ). Following the news, MedReleaf stock was heavily traded with a volume of 3.3 million shares and closed at 25.3 Canadian dollars. Read MedReleaf Stock Rises on Aurora Cannabis Acquisition to learn more.

Looks Like Aurora Cannabis Is Trying To 'Amazon' The Pot Market

2018-05-17 seekingalpha
CEO Terry Booth says the company isn't going to stop at MedReleaf - looking for more acquisitions.

CANADA STOCKS-Energy stocks boost TSX as oil tops $80

2018-05-17 reuters
May 17 - Canada’s main stock index rose on Thursday, gaining for the 10th straight session, led by the energy sector as oil prices hit $80 a barrel for the first time since November 2014.

Why Analysts Are Loving Cannabis Stocks in May

2018-05-17 marketrealist
With the upcoming legalization of cannabis in Canada, the sector has heated up with news of new product development, partnerships, and the appointment and elevation of experienced professionals. The industry is also consolidating with mergers and acquisitions happening quite often.

CANADA STOCKS - TSX rises 0.06 pct, boosted by industrials

2018-05-16 reuters
NEW YORK, May 16 (Reuters) - * The Toronto Stock Exchange’s S&P/TSX rose 10.25 points, or 0.06 percent, to 16,108.06. * The biggest contributor to the TSX gain was Canadian National Railway with 13.3 net index points. The industrials sector was the top contributor with 9.8 net points. * Leading the index were CES Energy Solutions Corp, up 6.0 percent, First Quantum Minerals Ltd, up 5 percent, and West Fraser Timber Co Ltd, higher by 4.

CANADA STOCKS-TSX flat as gains in materials offset by energy losses

2018-05-16 reuters
(Reuters) - Canada’s main stock index was little changed on Wednesday as gains in materials and industrials sectors offset a drop in energy stocks.

Cronos Group Stock Falls ~5% after Q1 Earnings Release

2018-05-16 marketrealist
Cronos Group (CRON) reported its first-quarter earnings on May 15. The company’s sales rose almost 4.8 times year-over-year to 2.9 million Canadian dollars from 0.5 million Canadian dollars in the first quarter of 2017. Sequentially, sales grew 83% from 1.3 million Canadian dollars.

CANADA STOCKS - TSX rises 0.08 pct, extends winning streak

2018-05-15 reuters
NEW YORK, May 15 (Reuters) - * The Toronto Stock Exchange’s S&P/TSX rose 12.20 points, or 0.08 percent, to 16,097.81. * The biggest contributor to the TSX gain was Canadian National Railway Co, with 10.1 net index points. Industrials were the top sector contributor with 13 net points. * Leading the index were Element Fleet Management Corp, up 12.1 percent, Aphria Inc, up 7.5 percent, and Boyd Group Income Fund, higher by 4.

Canada’s marijuana industry looks abroad for growth

2018-05-15 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to:

PRESS DIGEST- Canada - May 15

2018-05-15 reuters
May 15 (Reuters) - The following are the top stories from select Canadian newspapers. Reuters has not verified these stories and does not vouch for their accuracy.

Deals of the day-Mergers and acquisitions

2018-05-15 reuters
May 15 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1100 GMT on Tuesday:

Aurora Cannabis to buy MedReleaf for $3.2 billion

2018-05-15 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to:

ACBFF : Aurora Cannabis (TSXV:ACB) Analysis and Research Report

2017-12-09 - Asif

Aurora Cannabis is a community minded, Canadian owned and operated company. Nestled in the shadow of the Rockies in Mountain View County, its plants are carefully brought to harvest in its purpose-built 55,200 square foot facility. Fed with water from the Canadian Rockies, cared for in a state-of-the-art facility designed to produce the cleanest, safest medical cannabis available on the market, we're proud of its facility, its team and its product. Cultivating, harvesting, and selling Canadian Medical Marijuana, Aurora is your best chance to experience the healing power of nature. On November 27th, 2015 Aurora was officially issued its license to sell. This marked a monumental step in the continued success and evolution of Aurora as one of Canada's top medical marijuana companies. Aurora is one of 35 licensed producers across Canada and the only one located in Alberta. Boasting the second highest square footage approved for production in Canada, Aurora was the first applicant ...

Related Articles

TROV: TrovaGene Analysis and Research Report

14m - Asif

BUSINESS TrovaGene is a clinical-stage, precision medicine oncology therapeutics company. The company's primary focus is to develop oncology therapeutics for improved cancer care and to optimize drug development by leveraging its proprietary Precision Cancer Monitoring® (“PCM”) technology in tumor genomics. The company's lead drug candidate, PCM-075, is a Polo-like Kinase 1 (“PLK1”) selective adenosine triphosphate (“ATP”) competitive inhibitor. PCM-075 has shown preclinical antitumor activity as a single agent and synergy in combination with more than ten different chemotherapeutics and targeted therapies, such as Zytiga® (abiraterone acetate), Beleodaq® (belinostat), Quizartinib (AC220), a development stage FLT3 inhibitor, and Velcade® (bortezomib) in Acute Myeloid Leukemia (“AML”), metastatic Castration-Resistant Prostate Cancer (“mCRPC”) and other hematologic and solid tumor cancers. On March 15, 2017, the company announced the licensing of PCM-075, a PLK1 inhibitor...

SGMO: Sangamo BioSciences Analysis and Research Report

2018-05-19 - Asif

OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...

HMNY: Helios and Matheson Analytics Analysis and Research Report

2018-05-19 - Asif

Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...

CUSIP: 05156X108